Home
Conditions
Endocrine Gland Neoplasms

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,089 public trials 1,370 recruiting studies

Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Not Yet Recruiting

Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer

NCT06571461

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions

NCT06563232

Conditions: Abdominal Neoplasm, Excluding Pancreas Neoplasm, Abdominal Neoplasms, Digestive System Diseases, +12 more
Locations: Tongji Hospital, Tongji Medical College, HUST Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence

NCT06558019

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma

NCT06556186

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer

NCT06552858

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Fudan university shanghai cancer center, Deparment of gynecologic oncology Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients

NCT06544460

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Fudan university shanghai cancer center, Deparment of gynecologic oncology Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction Results

NCT06541171

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations: Fondazione Policlinico Universitaro "A. Gemelli" IRCCS Roma, Italy

View Trial Details

Not Yet Recruiting

Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer

NCT06539091

Conditions: Adnexal Diseases, Bone Mineral Density, Carcinoma, +21 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of XS-02 Capsules in Patients With Advanced Solid Tumors

NCT06531486

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +23 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation

NCT06531291

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +15 more
Locations: Renji hospital Shanghai, Shanghai Municipality, China

View Trial Details

Endocrine Gland Neoplasms

Endocrine Gland Neoplasms trial results

Related conditions